QBE INSURANCE GROUP LIMITED (QBE)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

QBE - QBE INSURANCE GROUP LIMITED

FNArena Sector : Insurance
Year End: December
GICS Industry Group : Insurance
Debt/EBITDA: N/A
Index: ASX20 | ASX50 | ASX100 | ASX200 | ASX300 | ALL-ORDS

QBE Insurance Group is an Australian insurance company operating in North America, Europe, Australia & New Zealand and the Asia Pacific region. It was listed in 1973 following the merger of three companies whose names represent the letters of the combined company.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$19.32

19 Dec
2024

0.400

OPEN

$18.65

2.11%

HIGH

$19.32

6,470,339

LOW

$18.65

TARGET
$20.703 7.2% upside
Franking for last dividend paid out: 20%
OTHER COMPANIES IN THE SAME SECTOR
AUB . CVW . FCL . GDG . HLI . IAG . MPL . NHF . NOL . SDF . SUN . TWR .
FNARENA'S MARKET CONSENSUS FORECASTS
QBE: 1
Title FY24
Forecast		 FY25
Forecast
EPS (cps) 165.0 xxx
DPS (cps) 70.1 xxx
EPS Growth N/A xxx
DPS Growth N/A xxx
PE Ratio 11.6 xxx
Dividend Yield 3.7% xxx
Div Pay Ratio(%) 42.5% xxx
This company reports in USD.
All estimates have been converted into AUD by FNArena at present FX values.

Dividend yield today if purchased 3 years ago: 5.49%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 3.24

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 16/08 - ex-div 24c (franking 20%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx132.0
DPS All xxxxxxxxxxxxxxx62.0
Sales/Revenue xxxxxxxxxxxxxxx32,609.4 M
Book Value Per Share xxxxxxxxxxxxxxx976.0
Net Operating Cash Flow xxxxxxxxxxxxxxx2,264.4 M
Net Profit Margin xxxxxxxxxxxxxxx6.26 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx14.12 %
Return on Invested Capital xxxxxxxxxxxxxxx11.64 %
Return on Assets xxxxxxxxxxxxxxx3.20 %
Return on Equity xxxxxxxxxxxxxxx14.67 %
Return on Total Capital xxxxxxxxxxxxxxx17.27 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx1,565.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx1,111 M
Long Term Debt xxxxxxxxxxxxxxx3,413 M
Total Debt xxxxxxxxxxxxxxx4,524 M
Goodwill - Gross xxxxxxxxxxxxxxx2,339 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx2,002 M
Price To Book Value xxxxxxxxxxxxxxx1.52

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx253.1 M
Capex % of Sales xxxxxxxxxxxxxxx0.78 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx1,674 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx42,424 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.7

No. Of Recommendations

7
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

xx/xx/xxxx

3

xxxxxxxxx xx xxxx xxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

28/11/2024

1

Outperform

$21.30

10.25%

QBE Insurance has released a Sep Q trading update, and impressions are in line with Macquarie's expectations. The US Middle Market portfolio is rolling off faster than anticipated which was a positive through the North American hurricane season.

The trajectory on catastrophes through ten months and reiteration of guidance are both positive, the broker suggests.

Given additional confidence in the North American turnaround story and flattening forward curves, Macquarie maintains an Outperform rating with QBE its preference among Australian General Insurers. Target rises to $21.30 from $20.80.

FORECAST
Macquarie forecasts a full year FY24 dividend of 80.00 cents and EPS of 160.22 cents.
Macquarie forecasts a full year FY25 dividend of 75.00 cents and EPS of 158.71 cents.

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

3

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Goldman Sachs

28/11/2024

1

Buy

$20.00

3.52%

QBE Insurance's 3Q24 trading update suggests the insurer's combined operating ratio improved by around 50bps on Goldman Sachs' estimate.

The analyst notes 2024 year-to-date group rate increases are tracking ahead of inflation, and perils are tracking "favourably" below the 2024 allowance of US$105m.

The Buy rating is retained, with the broker highlighting valuation appeal at around 11.5x FY25 earnings. The target price remains unchanged at $20.

FORECAST
Goldman Sachs forecasts a full year FY24 dividend of 56.00 cents and EPS of 160.22 cents.
Goldman Sachs forecasts a full year FY25 dividend of 58.00 cents and EPS of 173.82 cents.
Access Extra Coverage Research History >

QBE STOCK CHART

FNArena News on QBE

1
Rudi’s View: Banks, WiseTech, Redox & Integral Diagnostics

Dec 19 2024 - Rudi's View
2
Rudi’s View: Best Buys & Smaller Cap Favourites

Dec 12 2024 - Rudi's View
3
Weekly Ratings, Targets, Forecast Changes – 06-12-24

Dec 09 2024 - Weekly Reports
4
Rudi’s View: In Santa We Trust (?)

Dec 05 2024 - Rudi's View
5
Australian Broker Call *Extra* Edition – Dec 02, 2024

Dec 02 2024 - Daily Market Reports

Latest Insurance News

1
ESG Focus: The Little Big Things – 21-11-2024

Nov 21 2024 - ESG Focus
2
New-Look Suncorp Ready To Rumble

Nov 14 2024 - Australia
3
Steadfast’s Long March

Jul 02 2024 - Australia
4
AUB Group Shares Poised For Break-Out

Jun 13 2024 - Technicals
5
SMSFundamentals: Older People Are Life Insurers’ Future Challenge

Oct 26 2023 - SMSFundamentals
6
Australian Insurers And The Weather

Oct 19 2023 - Feature Stories
7
Steadfast Group’s US Entry Full Of Promise

Oct 11 2023 - Australia
8
Pros And Cons Of Insurance Companies

Aug 02 2023 - Australia
9
Underlying Trends Positive For QBE Insurance

May 15 2023 - Australia
10
Rates Over Reinsurance For General Insurers 

Feb 01 2023 - Australia